During the last session, Turnstone Biologics Corp (NASDAQ:TSBX)’s traded shares were 0.58 million, with the beta value of the company hitting 2.24. At the end of the trading day, the stock’s price was $0.50, reflecting an intraday gain of 5.06% or $0.03. The 52-week high for the TSBX share is $5.75, that puts it down -1050.0 from that peak though still a striking 12.0% gain since the share price plummeted to a 52-week low of $0.44. The company’s market capitalization is $11.51M, and the average intraday trading volume over the past 10 days was 0.16 million shares, and the average trade volume was 276.53K shares over the past three months.
Turnstone Biologics Corp (TSBX) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.33. TSBX has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.86.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Turnstone Biologics Corp (NASDAQ:TSBX) trade information
Turnstone Biologics Corp (TSBX) registered a 5.06% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 5.06% in intraday trading to $0.50, hitting a weekly high. The stock’s 5-day price performance is -2.77%, and it has moved by 4.86% in 30 days. Based on these gigs, the overall price performance for the year is -85.97%. The short interest in Turnstone Biologics Corp (NASDAQ:TSBX) is 0.39 million shares and it means that shorts have 2.82 day(s) to cover.
The extremes of the forecast give a target low and a target high price of $0.5 and $0.5 respectively.
Turnstone Biologics Corp (TSBX) estimates and forecasts
Statistics show that Turnstone Biologics Corp has outperformed its competitors in share price, compared to the industry in which it operates. Turnstone Biologics Corp (TSBX) shares have gone down -81.69% during the last six months, with a year-to-date growth rate more than the industry average at 19.46% against 17.10. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 14.00% this quarter and then drop -19.20% in the quarter after that.
While earnings are projected to return 26.57% in 2024, the next five years will return 17.90% per annum.
TSBX Dividends
Turnstone Biologics Corp is due to release its next quarterly earnings on 2024-Aug-14. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
